TrialBritish journal of clinical pharmacology2018

Clinical safety, tolerability, pharmacokinetics and effects on urinary electrolyte excretion of AZD9977, a novel, selective mineralocorticoid receptor modulator.

Fredrik Erlandsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.